Early-Stage Alzheimer’s Disease

Country:

Washington, USA and Minnesota, USA

Target group:

Patients with early-stage Alzheimer’s disease

Use case:

The University of Washington in Seattle and the Center for Memory and Aging at the HealthPartners Institute in Minnesota are using the SGMA Index to study the effects of transcranial magnetic stimulation (TMS) on memory in patients with early-stage Alzheimer’s disease (AD). The goal is to determine if TMS can stabilize or reverse memory impairment.

Alzheimer Brain

Looking for support?

Connect with our dedicated research team—we’re ready to assist you!

Researcher at MemoryLab

Thomas
Wilschut

Researcher & Partnership Coordinator

Looking for support?

Connect with our dedicated research team—we’re ready to assist you!

anais-capik

Anais Capik

Project Coordinator

Apply to use the SGMA Index

Fill out the form

Or send us a message

Researcher at MemoryLab

Thomas Wilschut

Researcher & Partnership Coordinator

anais-capik

Anais Capik

Project Coordinator

Offerte aanvragen?

Vul het onderstaande formulier in:

Of mail naar:

Aan de slag!

Wilt u meer weten?

Vul het onderstaande formulier in:

Of mail naar: